A

German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients

Annals of Oncology

Authors 0

  1. Author list not loaded yet.

Cited by 5 stored of 27

5 results

References 0